Alzheimer’s disease like pathology induced six weeks after aggregated amyloid-beta injection in rats: increased oxidative stress and impaired long-term memory with anxiety-like behavior
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Alzheimer’s disease like pathology induced six weeks after aggregated amyloid-beta injection in rats: increased oxidative stress and impaired long-term memory with anxiety-like behavior
Authors
Keywords
-
Journal
NEUROLOGICAL RESEARCH
Volume 38, Issue 9, Pages 838-850
Publisher
Informa UK Limited
Online
2016-07-19
DOI
10.1080/01616412.2016.1209337
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The antineoplastic drug flavopiridol reverses memory impairment induced by Amyloid-ß 1-42 oligomers in mice
- (2016) Gian Marco Leggio et al. PHARMACOLOGICAL RESEARCH
- Hippocampal Injections of Oligomeric Amyloid β-peptide (1–42) Induce Selective Working Memory Deficits and Long-lasting Alterations of ERK Signaling Pathway
- (2016) Pierre Faucher et al. Frontiers in Aging Neuroscience
- Acute amnestic encephalopathy in amyloid-β oligomer–injected mice is due to their widespread diffusion in vivo
- (2015) Stéphane Epelbaum et al. NEUROBIOLOGY OF AGING
- Systematic analysis of time-dependent neural effects of soluble amyloid β oligomers in culture and in vivo: Prevention by scyllo-inositol
- (2015) Ming Jin et al. NEUROBIOLOGY OF DISEASE
- Methanolic Extract of Piper nigrum Fruits Improves Memory Impairment by Decreasing Brain Oxidative Stress in Amyloid Beta(1–42) Rat Model of Alzheimer’s Disease
- (2014) Lucian Hritcu et al. CELLULAR AND MOLECULAR NEUROBIOLOGY
- Alzheimer's Disease-Like Pathology Induced by Amyloid-β Oligomers in Nonhuman Primates
- (2014) Leticia Forny-Germano et al. JOURNAL OF NEUROSCIENCE
- Amyloid Beta: Multiple Mechanisms of Toxicity and Only Some Protective Effects?
- (2014) Paul Carrillo-Mora et al. Oxidative Medicine and Cellular Longevity
- Comparative efficacy of Ocimum sanctum L. and Ocimum basilicum L. essential oils against amyloid beta (1–42)-induced anxiety and depression in laboratory rats
- (2014) Veronica Gradinariu et al. PHYTOCHEMISTRY REVIEWS
- Granulocyte-Colony Stimulating Factor Attenuates Oligomeric Amyloid β Neurotoxicity by Activation of Neprilysin
- (2014) Yukiko Doi et al. PLoS One
- Memantine Rescues Transient Cognitive Impairment Caused by High-Molecular-Weight A Oligomers But Not the Persistent Impairment Induced by Low-Molecular-Weight Oligomers
- (2013) C. P. Figueiredo et al. JOURNAL OF NEUROSCIENCE
- 7,8-Dihydroxyflavone Prevents Synaptic Loss and Memory Deficits in a Mouse Model of Alzheimer’s Disease
- (2013) Zhentao Zhang et al. NEUROPSYCHOPHARMACOLOGY
- Alzheimer's Disease Related Markers, Cellular Toxicity and Behavioral Deficits Induced Six Weeks after Oligomeric Amyloid-β Peptide Injection in Rats
- (2013) Charleine Zussy et al. PLoS One
- Neurotoxic amyloid beta oligomeric assemblies recreated in microfluidic platform with interstitial level of slow flow
- (2013) Yoon Jung Choi et al. Scientific Reports
- Neurotoxicity of Amyloid -Protein: Synaptic and Network Dysfunction
- (2013) L. Mucke et al. Cold Spring Harbor Perspectives in Medicine
- Amyloid β-Peptide (1–42)-Induced Oxidative Stress in Alzheimer Disease: Importance in Disease Pathogenesis and Progression
- (2012) D. Allan Butterfield et al. ANTIOXIDANTS & REDOX SIGNALING
- Effects of Perceived Long-Term Stress on Subjective and Objective Aspects of Memory and Cognitive Functioning in a Middle-Aged Population-Based Sample
- (2012) Michael Rönnlund et al. JOURNAL OF GENETIC PSYCHOLOGY
- Neurotoxicity and Memory Deficits Induced by Soluble Low-Molecular-Weight Amyloid- 1-42 Oligomers Are Revealed In Vivo by Using a Novel Animal Model
- (2012) J. Brouillette et al. JOURNAL OF NEUROSCIENCE
- Soluble A Promotes Wild-Type Tau Pathology In Vivo
- (2012) M. A. Chabrier et al. JOURNAL OF NEUROSCIENCE
- The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes
- (2012) Iryna Benilova et al. NATURE NEUROSCIENCE
- Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapy
- (2012) Mark J. Millan et al. NATURE REVIEWS DRUG DISCOVERY
- Deregulation of hypothalamic-pituitary-adrenal axis functions in an Alzheimer's disease rat model
- (2012) Anthony Brureau et al. NEUROBIOLOGY OF AGING
- Time-Course and Regional Analyses of the Physiopathological Changes Induced after Cerebral Injection of an Amyloid β Fragment in Rats
- (2011) Charleine Zussy et al. AMERICAN JOURNAL OF PATHOLOGY
- Moderate Grade Hyperammonemia Induced Concordant Activation of Antioxidant Enzymes is Associated with Prevention of Oxidative Stress in the Brain Slices
- (2011) Aditi Mehrotra et al. NEUROCHEMICAL RESEARCH
- Phenylbutyrate rescues dendritic spine loss associated with memory deficits in a mouse model of Alzheimer disease
- (2010) Ana Ricobaraza et al. HIPPOCAMPUS
- A causative link between the structure of aberrant protein oligomers and their toxicity
- (2010) Silvia Campioni et al. Nature Chemical Biology
- Amyloid-β–induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks
- (2010) Jorge J Palop et al. NATURE NEUROSCIENCE
- Preparation and characterization of toxic Aβ aggregates for structural and functional studies in Alzheimer's disease research
- (2010) Asad Jan et al. Nature Protocols
- Structural conversion of neurotoxic amyloid-β1–42 oligomers to fibrils
- (2010) Mahiuddin Ahmed et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Amyloid β-peptide levels in laser capture microdissected cornu ammonis 1 pyramidal neurons of Alzheimerʼs brain
- (2010) Mikio Aoki et al. NEUROREPORT
- Synthetic amyloid- oligomers impair long-term memory independently of cellular prion protein
- (2010) C. Balducci et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Intracellular accumulation of amyloid-beta – a predictor for synaptic dysfunction and neuron loss in Alzheimer’s disease
- (2010) Bayer Frontiers in Aging Neuroscience
- Oxidative Stress and Neurodegenerative Diseases: A Review of Upstream and Downstream Antioxidant Therapeutic Options
- (2009) Bayani Uttara et al. Current Neuropharmacology
- Depression and Alzheimer's disease: Neurobiological links and common pharmacological targets
- (2009) Filippo Caraci et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Measurement of superoxide dismutase, catalase and glutathione peroxidase in cultured cells and tissue
- (2009) Christine J Weydert et al. Nature Protocols
- Comparison of Alzheimer A (1-40) and A (1-42) amyloid fibrils reveals similar protofilament structures
- (2009) M. Schmidt et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Soluble oligomers of the amyloid β-protein impair synaptic plasticity and behavior
- (2008) Dennis J. Selkoe BEHAVIOURAL BRAIN RESEARCH
- Epigenetic targets of HDAC inhibition in neurodegenerative and psychiatric disorders
- (2008) T ABEL et al. CURRENT OPINION IN PHARMACOLOGY
- Amyloid-cholinesterase interactions
- (2008) Nibaldo C. Inestrosa et al. FEBS Journal
- The neuroprotective role of melatonin against amyloidβpeptide injected mice
- (2008) J. Gunasingh Masilamoni et al. FREE RADICAL RESEARCH
- Parenchymal and vascular Aβ-deposition and its effects on the degeneration of neurons and cognition in Alzheimer's disease
- (2008) Dietmar Rudolf Thal et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory
- (2008) Ganesh M Shankar et al. NATURE MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now